Free Trial

Replimune Group (REPL) Insider Trading & Ownership

Replimune Group logo
$12.49 +0.48 (+4.00%)
(As of 12/20/2024 05:16 PM ET)

Replimune Group (NASDAQ:REPL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$1.01 M
Get REPL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Replimune Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

REPL Insider Buying and Selling by Quarter

Replimune Group Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/16/2024Sushil PatelCEOSell10,000$12.42$124,200.00  
11/18/2024Konstantinos XynosInsiderSell7,246$10.78$78,111.88  
8/16/2024Emily Luisa HillCFOSell8,938$10.18$90,988.84  
6/7/2024Konstantinos XynosInsiderSell15,881$7.50$119,107.50  
5/16/2024Andrew SchwendenmanCAOSell2,298$6.47$14,868.06  
5/16/2024Christopher SarchiInsiderSell2,218$6.47$14,350.46  
5/16/2024Colin LoveCOOSell17,615$6.47$113,969.05  
5/16/2024Philip Astley-SparkeChairmanSell37,928$6.47$245,394.16  
5/16/2024Robert CoffinDirectorSell11,464$6.47$74,172.08  
5/16/2024Sushil PatelCEOSell20,194$6.47$130,655.18  
(Data available from 1/1/2013 forward)

REPL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Replimune Group includes Andrew Schwendenman, Christopher Sarchi, Colin Love, Emily Luisa Hill, Fund Iv L.P. Omega, Jean M Franchi, Konstantinos Xynos, Pamela Esposito, Philip Astley-Sparke, Robert Coffin, Sushil Patel, and Tanya Lewis. Learn more on insiders at REPL.

8.80% of Replimune Group stock is owned by insiders. Learn more on REPL's insider holdings.

The following insiders have sold REPL shares in the last 24 months: Andrew Schwendenman ($14,868.06), Christopher Sarchi ($14,350.46), Colin Love ($308,457.80), Emily Luisa Hill ($90,988.84), Jean M Franchi ($204,885.55), Konstantinos Xynos ($277,077.34), Pamela Esposito ($938,999.58), Philip Astley-Sparke ($568,525.26), Robert Coffin ($74,172.08), Sushil Patel ($535,983.93), and Tanya Lewis ($309,411.60).

Insiders have sold a total of 254,916 Replimune Group shares in the last 24 months for a total of $3,337,720.50 sold.

Replimune Group Key Executives

  • Mr. Philip Astley-Sparke F.S.A. (Age 53)
    CEO & Director
    Compensation: $1.07M
  • Dr. Sushil Patel Ph.D. (Age 53)
    Chief Strategy Officer
    Compensation: $665.05k
  • Dr. Robert Coffin Ph.D. (Age 59)
    Founder, President, Chief Research & Development Officer and Director
    Compensation: $785.89k
  • Ms. Emily Luisa Hill (Age 44)
    Chief Financial Officer
    1 recent trades
  • Dr. Colin A. Love Ph.D. (Age 66)
    Chief Operating Officer
    Compensation: $419.37k
  • Mr. Andrew Schwendenman (Age 48)
    Chief Accounting Officer & Treasurer
  • Dr. Pamela Esposito Ph.D. (Age 50)
    Chief Business Officer
    Compensation: $464.63k
  • Ms. Tanya N. Lewis M.S. (Age 53)
    Chief Development Operations Officer
    Compensation: $4.7k
  • Mr. Christopher Sarchi (Age 56)
    Chief Commercial Officer
  • Dr. Konstantinos Xynos M.B.A. (Age 58)
    M.D., Ph.D., Chief Medical Officer


This page (NASDAQ:REPL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners